|
|
.
See Category: Diseases of the eye and adnexa
ICD-10 (CM) Code and Descriptor
|
H40.20X3 |
Unspecified primary angle-closure glaucoma, severe stage
|
H4020X3 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 48.49%
|
21.11%
|
10.44%
|
3.02%
|
4.41%
|
2.55%
|
1.16%
|
2.32%
|
0.46%
|
1.39%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H40.20X3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
85
|
85
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
49
|
49
|
|
92083
|
EXTENDED VISUAL FIELD XM |
41
|
41
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
32
|
32
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
17
|
37
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
15
|
15
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
15
|
32
|
|
92020
|
GONIOSCOPY |
11
|
11
|
|
J3010
|
FENTANYL CITRATE INJECTION |
11
|
16
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
11
|
216
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
10
|
82
|
|
J2405
|
ONDANSETRON HCL INJECTION |
9
|
33
|
|
J3473
|
HYALURONIDASE RECOMBINANT |
8
|
895
|
|
66761
|
REVISION OF IRIS |
8
|
8
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
8
|
8
|
|
66180
|
AQUEOUS SHUNT EYE W/GRAFT |
8
|
8
|
|
G0467
|
FQHC VISIT, ESTAB PT |
6
|
6
|
|
J7120
|
RINGERS LACTATE INFUSION |
6
|
6
|
|
C1762
|
CONN TISS, HUMAN(INC FASCIA) |
5
|
5
|
|
82962
|
GLUCOSE BLOOD TEST |
5
|
5
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H40.20X3 related to the following DRG Codes:
124-125
|
